Search clinical trials for: Beta-hydroxybutyric acid

Total 29460 results

Biotec Pharmacon ASA

Completed

Effect of SBG in Patients With Breast Cancer

Breast Cancer

Norway
Quanta Medical
Laboratoires Iprad-Vegebom

Terminated

A Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoïditis Among Adults (DIVA)

Diverticular Sigmoïditis
Guy's and St Thomas' NHS Foundation Trust

Active, not recruiting

A Study to Investigate the Effect of HMB on Skeletal Muscle Wasting in Early Critical Illness (HMB-ICU)

Critical Illness

United Kingdom
University of Roma La Sapienza

Completed

Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation (HMB)

Sarcopenia

Italy
University of Sao Paulo

Unknown

Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic Inflammation

Atherosclerosis | Morbid Obesity | Systemic Inflammation

Brazil
Georgetown University
University of Maryland, Baltimore; National Center for Complementary and Integrative...

Completed

Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics (YOBIOTIC)

Antibiotic-associated Diarrhea

United States
Cairo University

Completed

Effect of Preoperative Amoxicillin/Clavulanic Acid Combination on Postoperative Endodontic Pain

Symptomatic Periapical Periodontitis

Egypt
Antonio Barone

Completed

Antibiotic Therapy in Erupted Tooth Extractions

Tooth Extraction | Post-Op Complication | Amoxicillin
Janssen Research & Development, LLC

Terminated

A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections

Rupture | Abdominal Pain | Appendicitis | Peritonitis | Abdominal Abscess | Infection | Ileus | Intestinal Perforation | Abdomen, Acute | Abscess, Intra-Abdominal

United States, Argentina, Colombia, Chile, Panama, Lithuania, Latvia, Brazil
Bayer
Novartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe Ltd

Completed

EPID Multiple Sclerosis Pregnancy Study

Multiple Sclerosis

Finland
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI); Pharmavite LLC; Seafood Industry Research Fund

Active, not recruiting

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

Stage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Instituto Mexicano del Seguro Social
Hospital Civil de Guadalajara

Completed

Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.

Human Immunodeficiency Virus
Rigshospitalet, Denmark
Novo Nordisk A/S; Simon Spies Fonden; Helge Peetz og Verner Peetz og hustru Vilma...

Recruiting

Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock (DOBERMANN)

Acute Myocardial Infarction | Cardiogenic Shock

Denmark
Corporacion Parc Tauli

Completed

Randomized Clinical Trial to Compare the Treatment of Mild Acute Diverticulitis With or Without Antibiotics

Acute Diverticulitis

Spain
ArQule, Inc. (a wholly owned subsidiary of Merck...

Completed

ARQ 501 in Combination With Docetaxel in Patients With Cancer

Carcinoma

United States
Amicus Therapeutics

Completed

A Study to Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.

Fabry Disease

Japan, Taiwan, Turkey, United States, Brazil
Central Hospital, Nancy, France

Completed

Peritoneal 1.3-ß-D-glucan for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients (pBDG2) (pBDG2)

Candidiasis, Invasive | Critically Ill | Intra Abdominal Infections | Peritoneal Candidiasis

France
Genzyme, a Sanofi Company

Completed

A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease

Fabry Disease

Japan
RegeneRx Biopharmaceuticals, Inc.

Completed

Study of Thymosin Beta 4 in Patients With Pressure Ulcers

Pressure Ulcers

United States
Marilia Medicine School

Completed

Pterygium Treatment Using Single Beta-therapy as Adjuvant Treatment Compared to Conjunctival Autograft

Pterygium

Brazil
Biocad

Completed

Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis

Multiple Sclerosis

Russian Federation
Combined Military Hospital Abbottabad

Completed

Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma

Melasma

Pakistan
OHSU Knight Cancer Institute
Oregon Health and Science University; Kuni Foundation

Recruiting

Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA Melanoma

Clinical Stage IIA Cutaneous Melanoma AJCC v8

United States
Unilever R&D
UMC Utrecht

Completed

The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD

Healthy | Attention Deficit Hyperactivity Disorder

Netherlands
RegeneRx Biopharmaceuticals, Inc.

Withdrawn

A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction

ST Elevation Myocardial Infarction | Acute Myocardial Infarction | STEMI
Bayer

Completed

Physical Disability in Patients Treated With Betaferon

Multiple Sclerosis

Colombia
Metabolic Technologies Inc.
Iowa State University

Completed

Effects of HMB Supplementation on Recovery Following ACL Surgery

ACL Injury

United States
Western Galilee Hospital-Nahariya

Unknown

Prevention of Contrast Induced Nephropathy by Erythropoietin

Diabetes | Chronic Kidney Insufficiency

Israel
Cinnagen

Completed

Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis (RRMS)

Iran, Islamic Republic of
Merck KGaA, Darmstadt, Germany

Completed

A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis (IMPROVE)

Multiple Sclerosis, Relapsing-Remitting
Tufts University

Completed

Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers

Cardiovascular Diseases | Hyperlipidemias | Metabolic Syndrome X

United States
Shanghai Mental Health Center
Harbin Medical University; Qingdao Mental Health Center

Recruiting

Multi-factor Model Constraction for Early Warning and Diagnosis of MDD

Bipolar Disorder | Major Depressive Disorder | Omega-3 Fatty Acids

China
East Carolina University

Completed

High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions

Brain Concussion | Mild Concussion | Cerebral Concussion

United States
The Cleveland Clinic

Completed

Creatine Kinetics, Synthesis From Glycine and Response to Creatine and Amino Acid Supplement in Healthy Humans

Creatine Synthesis in Healthy Subjects

United States
Biocad

Completed

Open Label Study of Tolerability, Pharmacokinetics and Pharmacodynamics of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif® and Avonex® in Healthy Volunteers

Healthy

Russian Federation
St. John's Research Institute

Not yet recruiting

Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy. (EVANESCENT-DPN)

Diabetic Neuropathy Peripheral

India
Genzyme, a Sanofi Company

Completed

A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.

Fabry Disease

Japan
Genzyme, a Sanofi Company

Completed

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Fabry Disease

Czech Republic, Estonia, Poland, Slovakia
Genzyme, a Sanofi Company

Completed

A Study of Fabrazyme in Pediatric Patients With Fabry Disease

Fabry Disease

United States, France, Poland, United Kingdom
Synthes USA HQ, Inc.

Completed

Prospective, Multi-Center Clinical Outcomes Study Evaluating the chronOS Strip Combined With Bone Marrow Aspirate

Degeneration of Lumbar Intervertebral Disc

United States
Hadassah Medical Organization

Completed

Beta Glucosylceramide for Treatment of NASH

Compliance Behavior
Boston University

Completed

Fresolimumab In Systemic Sclerosis

Diffuse Systemic Sclerosis

United States
Biotec Pharmacon ASA

Completed

The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients

Oral Mucositis

Germany, United Kingdom
Biotec Pharmacon ASA

Completed

Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

Foot Ulcer

Russian Federation
Centre Hospitalier Universitaire Vaudois
BioPartners GmbH

Completed

Phase I BP Interferon (IFN) Beta-004

Multiple Sclerosis, Relapsing-Remitting
Koneksa Health

Completed

Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist (LEARN)

Moderate Asthma

United States
Genzyme, a Sanofi Company

Terminated

Study of the Effects of Fabrazyme Treatment on Lactation and Infants

Fabry Disease | Alpha Galactosidase A Deficiency

United States, Austria, United Kingdom
Sunstar Americas

Completed

Case Series of New Alloplastic Bone Graft Material

Oral Surgery | Periodontology

United States
Green Cross Corporation

Unknown

Study of Idursulfase-beta (GC1111) in Hunter Syndrome

Mucopolysaccharidosis II
Genzyme, a Sanofi Company
CRL/Medinet

Terminated

Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme

Fabry Disease | Chronic Kidney Disease, Stage IV (Severe)

United States

Search clinical trials for: Beta-hydroxybutyric acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations